Free Trial
→ Elon Set to Shock the World on July 1st? (From Brownstone Research) (Ad) Free PFE Stock Alerts

Pfizer (PFE) Short Interest Ratio & Short Volume

Pfizer logo
$24.00 -0.75 (-3.01%)
As of 01:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Pfizer Short Interest Data

Pfizer (PFE) has a short interest of 99.27 million shares. This marks a -11.29% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 45.84 million shares to cover all short positions.

Current Short Interest
99,270,000 shares
Previous Short Interest
111,910,000 shares
Change Vs. Previous Month
-11.29%
Dollar Volume Sold Short
$2.44 billion
Short Interest Ratio
2.3 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
5,685,370,000 shares
Percentage of Shares Shorted
1.75%
Today's Trading Volume
32,259,665 shares
Average Trading Volume
45,836,938 shares
Today's Volume Vs. Average
70%
Short Selling Pfizer?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Pfizer and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

PFE Short Interest Over Time

PFE Days to Cover Over Time

PFE Percentage of Float Shorted Over Time

Pfizer Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202599,270,000 shares $2.44 billion -11.3%N/A2.3 $24.63
6/30/2025111,910,000 shares $2.72 billion +4.9%2.0%2.4 $24.27
6/15/2025106,730,000 shares $2.62 billion +1.7%1.9%2.2 $24.51
5/31/2025104,990,000 shares $2.46 billion -2.2%1.9%2 $23.46
5/15/2025107,380,000 shares $2.42 billion -6.8%1.9%2 $22.57
4/30/2025115,160,000 shares $2.81 billion +7.2%N/A2.2 $24.41
4/15/2025107,430,000 shares $2.41 billion +10.2%1.9%2.1 $22.45
3/31/202597,490,000 shares $2.47 billion -1.7%1.7%2 $25.36
3/15/202599,170,000 shares $2.55 billion +4.4%1.8%2.2 $25.74
2/28/202594,960,000 shares $2.51 billion +6.6%1.7%2.3 $26.43
2/15/202589,120,000 shares $2.27 billion +21.1%1.6%2.2 $25.50
1/31/202573,570,000 shares $1.95 billion -19.8%N/A1.7 $26.51
1/15/202591,780,000 shares $2.41 billion +21.2%N/A2.1 $26.25
12/31/202475,710,000 shares $2.01 billion -11.3%N/A1.8 $26.53
12/15/202485,370,000 shares $2.18 billion -5.5%N/A2 $25.58
11/30/202490,380,000 shares $2.37 billion -4.4%N/A2.3 $26.21
11/15/202494,540,000 shares $2.34 billion +52.8%N/A2.5 $24.80
10/31/202461,870,000 shares $1.75 billion -12.8%N/A1.9 $28.29
10/15/202470,940,000 shares $2.09 billion +4.9%N/A2.3 $29.46
9/30/202467,620,000 shares $1.96 billion -9.7%N/A2.1 $28.94
9/15/202474,840,000 shares $2.19 billion +14.5%N/A2.4 $29.27
8/31/202465,380,000 shares $1.90 billion +5.9%N/A2 $29.01
8/15/202461,730,000 shares $1.77 billion -5.5%N/A1.8 $28.71
7/31/202465,330,000 shares $2.00 billion +17.3%N/A1.9 $30.54
7/15/202455,700,000 shares $1.62 billion -7.0%N/A1.5 $29.10
6/30/202459,890,000 shares $1.68 billion -3.5%N/A1.6 $27.98
6/15/202462,070,000 shares $1.71 billion -18.3%N/A1.6 $27.53
5/31/202475,970,000 shares $2.18 billion +8.2%N/A1.9 $28.68
5/15/202470,220,000 shares $2.02 billion +12.3%N/A1.7 $28.82
4/30/202462,510,000 shares $1.60 billion -8.2%N/A1.5 $25.61
4/15/202468,060,000 shares $1.76 billion +4.7%N/A1.6 $25.90
3/31/202465,000,000 shares $1.80 billion -9.3%N/A1.5 $27.75
3/15/202471,650,000 shares $2.00 billion +8.4%N/A1.7 $27.97
2/29/202466,120,000 shares $1.76 billion +9.0%N/A1.4 $26.55
2/15/202460,680,000 shares $1.67 billion +0.8%N/A1.3 $27.51
1/31/202460,190,000 shares $1.63 billion +4.5%N/A1.3 $27.06
1/15/202457,580,000 shares $1.65 billion +1.0%N/A1.4 $28.70
12/31/202357,030,000 shares $1.64 billion -7.9%N/A1.4 $28.79
12/15/202361,890,000 shares $1.65 billion +8.7%N/A1.6 $26.59
11/30/202356,940,000 shares $1.73 billion -1.0%N/A1.8 $30.44
GENIUS Act: Cancel Your Money? (Ad)

A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.

Get the free info kit with 3 strategies to sidestep digital dollar control.
11/15/202357,500,000 shares $1.74 billion +21.9%N/A2 $30.19
10/31/202347,180,000 shares $1.44 billion -13.5%N/A1.8 $30.56
10/15/202354,570,000 shares $1.75 billion +6.8%N/A2 $32.11
9/30/202351,080,000 shares $1.69 billion +2.3%N/A2.1 $33.17
9/15/202349,950,000 shares $1.70 billion -1.0%N/A2 $34.03
8/31/202350,460,000 shares $1.79 billion -3.7%N/A2.1 $35.38
8/15/202352,390,000 shares $1.85 billion +14.2%N/A1.9 $35.39
7/31/202345,860,000 shares $1.65 billion -13.0%N/A1.7 $36.06
7/15/202352,680,000 shares $1.91 billion -11.5%N/A2 $36.32
6/30/202359,510,000 shares $2.18 billion +8.0%N/A2.3 $36.68
6/15/202355,120,000 shares $2.19 billion -1.2%N/A2.2 $39.77
5/31/202355,780,000 shares $2.12 billion +21.5%N/A2.3 $38.02
5/15/202345,920,000 shares $1.71 billion +4.7%N/A1.9 $37.16
4/30/202343,870,000 shares $1.71 billion +6.0%N/A2.1 $38.89
4/15/202341,370,000 shares $1.70 billion -15.7%N/A1.9 $41.19
3/31/202349,070,000 shares $2.00 billion +11.2%N/A2.1 $40.80
3/15/202344,140,000 shares $1.78 billion +14.7%N/A2 $40.28
2/28/202338,490,000 shares $1.56 billion +1.2%N/A1.7 $40.57
2/15/202338,020,000 shares $1.65 billion -2.9%N/A1.7 $43.32
1/31/202339,170,000 shares $1.73 billion +5.4%N/A1.8 $44.16
1/15/202337,170,000 shares $1.78 billion -12.6%N/A1.7 $47.85
12/30/202242,530,000 shares $2.18 billion -26.7%N/A2 $51.24
12/15/202258,020,000 shares $3.11 billion -7.7%N/A2.7 $53.61
11/30/202262,830,000 shares $3.15 billion -10.3%N/A3.1 $50.13
11/15/202270,040,000 shares $3.40 billion +28.1%N/A3.6 $48.57
10/31/202254,690,000 shares $2.55 billion -12.5%N/A2.7 $46.55
10/15/202262,510,000 shares $2.68 billion +3.5%N/A3.2 $42.86
9/30/202260,370,000 shares $2.64 billion -5.5%N/A3.3 $43.76
9/15/202263,890,000 shares $2.94 billion +2.7%N/A3.6 $45.94
8/31/202262,200,000 shares $2.81 billion -8.5%N/A3.3 $45.23
8/15/202267,940,000 shares $3.38 billion +13.4%N/A3.4 $49.75
7/31/202259,900,000 shares $3.03 billion -11.1%N/A2.9 $50.51
7/15/202267,350,000 shares $3.49 billion -2.3%N/A3 $51.75
6/30/202268,930,000 shares $3.61 billion -10.5%N/A2.9 $52.43
6/15/202276,980,000 shares $3.73 billion -0.3%N/A3.1 $48.51
5/31/202277,200,000 shares $4.09 billion +33.9%N/A2.9 $53.04
5/15/202257,670,000 shares $2.88 billion -15.2%N/A2.1 $49.92
4/30/202267,990,000 shares $3.34 billion +8.5%N/A2.3 $49.07
4/15/202262,650,000 shares $3.33 billion +1.8%N/A2 $53.12
3/31/202261,560,000 shares $3.19 billion +0.6%N/A1.9 $51.77
3/15/202261,180,000 shares $3.19 billion -6.8%N/A1.7 $52.21
2/28/202265,640,000 shares $3.08 billion +3.8%N/A1.7 $46.94
2/15/202263,260,000 shares $3.15 billion -8.6%N/A1.5 $49.79
1/31/202269,220,000 shares $3.65 billion +8.0%N/A1.6 $52.69
1/15/202264,080,000 shares $3.52 billion +9.3%N/A1.5 $54.95
12/31/202158,640,000 shares $3.46 billion -11.2%N/A1.4 $59.05
12/15/202166,010,000 shares $3.88 billion +3.9%N/A1.7 $58.80
11/30/202163,560,000 shares $3.42 billion +0.0%N/A1.9 $53.73
11/15/202163,540,000 shares $3.15 billion +7.9%N/A2.1 $49.65
10/29/202158,880,000 shares $2.58 billion +8.1%N/A1.7 $43.74
GENIUS Act: Cancel Your Money? (Ad)

A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.

Get the free info kit with 3 strategies to sidestep digital dollar control.
10/15/202154,480,000 shares $2.26 billion +4.4%N/A1.7 $41.49
9/30/202152,180,000 shares $2.24 billion -3.5%N/A1.6 $43.01
9/15/202154,090,000 shares $2.42 billion -7.8%N/A1.7 $44.77
8/31/202158,670,000 shares $2.70 billion -4.5%N/A1.9 $46.07
8/13/202161,420,000 shares $2.98 billion +12.7%N/A2.1 $48.48
7/30/202154,500,000 shares $2.33 billion -11.0%1.0%2.1 $42.81
7/15/202161,240,000 shares $2.46 billion -3.0%N/A2.5 $40.09
6/30/202163,150,000 shares $2.47 billion +5.7%N/A2.4 $39.16
6/15/202159,770,000 shares $2.37 billion +1.3%N/A2.2 $39.59
5/28/202159,000,000 shares $2.29 billion +2.9%N/A2.2 $38.73
5/14/202157,320,000 shares $2.30 billion -1.2%N/A2 $40.10
4/30/202158,020,000 shares $2.24 billion -4.7%N/A1.9 $38.60
4/15/202160,890,000 shares $2.26 billion -7.6%N/A1.9 $37.17
3/31/202165,930,000 shares $2.38 billion -3.5%N/A2 $36.11
3/15/202168,320,000 shares $2.39 billion +1.0%N/A2 $34.94
2/26/202167,650,000 shares $2.29 billion +7.2%N/A1.7 $33.82
2/12/202163,120,000 shares $2.17 billion +0.0%N/A1.5 $34.43
1/29/202163,110,000 shares $2.26 billion -3.6%N/A1.3 $35.86
1/15/202165,480,000 shares $2.41 billion +0.3%N/A1.4 $36.75
12/31/202065,270,000 shares $2.40 billion +3.4%N/A1.5 $36.74
12/15/202063,140,000 shares $2.48 billion -0.9%N/A1.5 $39.21
11/30/202063,680,000 shares $2.37 billion -4.3%N/A1.7 $37.23
11/15/202066,530,000 shares $2.57 billion +44.9%N/A2.1 $38.62
10/30/202045,930,000 shares $1.62 billion +13.6%N/A1.7 $35.28
10/15/202040,440,000 shares $1.49 billion -10.5%N/A1.7 $36.86
9/30/202045,160,000 shares $1.66 billion +5.6%N/A1.8 $36.70
9/15/202042,750,000 shares $1.58 billion -5.4%N/A1.6 $36.96
8/31/202045,210,000 shares $1.71 billion -10.0%N/A1.5 $37.79
8/14/202050,220,000 shares $1.91 billion -6.1%N/A1.6 $38.06

PFE Short Interest - Frequently Asked Questions

What is Pfizer's current short interest?

Short interest is the volume of Pfizer shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 99,270,000 shares of PFE short. Learn More on Pfizer's current short interest.

What is a good short interest ratio for Pfizer?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PFE shares currently have a short interest ratio of 2.0. Learn More on Pfizer's short interest ratio.

Which institutional investors are shorting Pfizer?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: Mirae Asset Securities USA Inc., Wolverine Asset Management LLC, Allianz Asset Management GmbH, Twin Tree Management LP, Credit Industriel ET Commercial, Total Wealth Planning & Management Inc., DAVENPORT & Co LLC, IMC Chicago LLC, Quaker Wealth Management LLC, Jane Street Group LLC, CTC LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Millennium Management LLC, CMT Capital Markets Trading GmbH, Capital Markets Trading UK LLP, Cubist Systematic Strategies LLC, Royal Bank of Canada, Caption Management LLC, Nomura Holdings Inc., DRW Securities LLC, Twin Tree Management LP, Symmetry Peak Management LLC, HAP Trading LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Tradition Wealth Management LLC, Credit Agricole S A, Maven Securities LTD, Marathon Trading Investment Management LLC, Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, National Bank of Canada FI, Citigroup Inc., Delta Accumulation LLC, Bank of Nova Scotia, and Jefferies Financial Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Pfizer's short interest increasing or decreasing?

Pfizer saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 99,270,000 shares, a decrease of 11.3% from the previous total of 111,910,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Pfizer's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Pfizer: Amgen Inc. (2.74%), Gilead Sciences, Inc. (1.82%), Moderna, Inc. (19.34%), Novavax, Inc. (26.60%), Viatris Inc. (3.32%), AbbVie Inc. (0.89%), Bristol Myers Squibb Company (1.89%), Johnson & Johnson (0.76%), Eli Lilly and Company (0.90%), Merck & Co., Inc. (1.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Pfizer stock?

Short selling PFE is an investing strategy that aims to generate trading profit from Pfizer as its price is falling. PFE shares are trading up $1.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Pfizer?

A short squeeze for Pfizer occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PFE, which in turn drives the price of the stock up even further.

How often is Pfizer's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PFE, twice per month. The most recent reporting period available is July, 15 2025.



Related Companies
Short Interest Tools

This page (NYSE:PFE) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners
Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...
Crypto 101 Media | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
[Shocking New Report] U.S. Dollar To Crash?
The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…
Goldco Precious Metals | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
[Warning] Buffett Indicator hits new All-Time-High
Warren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...
Golden Portfolio | Sponsored
Market Crash Warning: How to Protect Your Wealth Before August 12th
China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...
American Alternative | Sponsored
Guess Who the Gvt Could Partner With Next?
The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...
Stansberry Research | Sponsored
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored